menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Early Antibiotic Use May Halt Progression of Severe Respiratory Illness in Young Children

close
Early Antibiotic Use May Halt Progression of Severe Respiratory Illness in Young Children
Restart
Resume
Choose a format
Media formats available:
Details
Comments
  • In Partnership with

  • Overview

    [Read the Article]

    Preschool children who experience repeated episodes of severe lower respiratory tract infections (LRTI) often present with symptoms like wheezing and difficulty breathing. A new study looked at whether the use of the common antibiotic, azithromycin, would help prevent progression of the illness, if given early enough in the episode.

    Researchers from Washington University in Saint Louis School of Medicine, studied more than 600 children, ranging from ages one to six years old, with a history of repeated episodes of severe respiratory illness. Children were randomly assigned to either receive azithromycin or a placebo early in these episodes.

    They found that children in the antibiotic group experienced a lower risk of progressing to severe LRTI than the placebo group.

    [Watch more videos of The JAMA Report]

Facebook Comments

Recommended
Details
Comments
  • In Partnership with

  • Overview

    [Read the Article]

    Preschool children who experience repeated episodes of severe lower respiratory tract infections (LRTI) often present with symptoms like wheezing and difficulty breathing. A new study looked at whether the use of the common antibiotic, azithromycin, would help prevent progression of the illness, if given early enough in the episode.

    Researchers from Washington University in Saint Louis School of Medicine, studied more than 600 children, ranging from ages one to six years old, with a history of repeated episodes of severe respiratory illness. Children were randomly assigned to either receive azithromycin or a placebo early in these episodes.

    They found that children in the antibiotic group experienced a lower risk of progressing to severe LRTI than the placebo group.

    [Watch more videos of The JAMA Report]

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 4/6/20